Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
BioJapan 2008

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 April 1972:
Vol. 176. no. 4031, pp. 170 - 171
DOI: 10.1126/science.176.4031.170
Prev | Table of Contents | Next

Articles

The Immune Reaction as a Stimulator of Tumor Growth

Richmond T. Prehn 1

1 Institute for Cancer Research, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111

Various numbers of spleen cells from specifically immunized mice were mixed with constant numbers of target tumor cells, and were inoculated subcutaneously into thymectomized, x-irradiated recipients. Small numbers of admixed immune spleen cells produced a statistically significant, and reproducible, acceleration of tumor growth in the inoculum as compared with controls of either nonimmune spleen cells or spleen cells from animals immune to a different, non-cross-reacting, tumor. Larger. numbers of specifically immune spleen cells, however, produced inhibition of tumor growth. These data imply that the normal immune reaction may have a dual function in relation to neoplasia: (i) stimulation of tumor growth, early in the course of the disease, or whenever the immune reaction is minimal; (ii) inhibition of tumor growth at other times.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.
S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi (2007)
PNAS 104, 6770-6775
   Abstract »    Full Text »    PDF »
Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines.
E. Gitelson, C. Hammond, J. Mena, M. Lorenzo, R. Buckstein, N. L. Berinstein, K. Imrie, and D. E. Spaner (2003)
Clin. Cancer Res. 9, 1656-1665
   Abstract »    Full Text »    PDF »
Variability of Placental Expression of Cyclin E Low Molecular Weight Variants.
A. Bukovsky, M. Cekanova, M. R. Caudle, J. Wimalasena, J. S. Foster, J. A. Keenan, and R. F. Elder (2002)
Biol Reprod 67, 568-574
   Abstract »    Full Text »    PDF »
Enhanced Growth of Primary Tumors in Cancer-prone Mice after Immunization against the Mutant Region of an Inherited Oncoprotein.
C. T. Siegel, K. Schreiber, S. C. Meredith, G. B. Beck-Engeser, D. W. Lancki, C. A. Lazarski, Y.-X. Fu, D. A. Rowley, and H. Schreiber (1999)
J. Exp. Med. 191, 1945-1956
   Abstract »    Full Text »    PDF »
Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogen.
L. Prehn and E. Lawler (1979)
Science 204, 309-310
   Abstract »    PDF »
Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice.
O. Stutman (1974)
Science 183, 534-536
   Abstract »    PDF »
Stimulation of Cells by Antibody.
W. T. Shearer, G. W. Philpott, and C. W. Parker (1973)
Science 182, 1357-1359
   Abstract »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)